2015

April 16th, 2015
,
Leading Professional Services firm deploys Savings-as-a-Service platform
April 13th, 2015
,
HealthTap spearheads the wearable care revolution, enabling you to manage your health and well-being right from your wrist with the new HealthTap App for Apple Watch
April 10th, 2015
,
Emeryville, Calif., April 10, 2015 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease. Adamas currently has multiple Phase 3 studies underway evaluating ADS-5102 for this indication, which currently has no FDA-approved treatment options.
March 11th, 2015
,
MADISON, N.J., March 10, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of Neurome™, a whole exome sequencing service designed to aid the diagnosis of rare neurological disorders in pediatric populations. Personalis, Inc., a leading genomics-based diagnostic laboratory, developed and performs the lab-developed test exclusively for Quest Diagnostics.
March 10th, 2015
,
Small- and mid-sized businesses (SMBs) now have a more flexible and convenient way to access working capital loans through a collaboration announced today by Kabbage Inc. and MasterCard.
February 12th, 2015
,
New Mobile Location Confirmation service uses real-time, geo-location technology to prevent unnecessary purchase declines by as much as 30%.
January 21st, 2015
,
Latest Funding Round Led by Temasek Holdings; Networking Startup Raises $95 Million to Date
January 21st, 2015
,
Latest Funding Round Led by Temasek Holdings; Networking Startup Raises $95 Million to Date
January 7th, 2015
,
Adaptive Biotechnologies Corporation today announced the acquisition of Sequenta, Inc. which is expected to expedite and expand the use of novel immunosequencing products for researchers and clinicians to diagnose, treat, and monitor patients with cancer, autoimmune disorders, and infectious diseases.